Rituximab in Pemphigus Foliaceous With Autoantibodies Against Both Desmoglein 1 and Desmoglein 3
| Data(s) |
16/10/2015
16/10/2015
2011
|
|---|---|
| Identificador |
10.1684/ejd.2011.1288 Eur J Dermatol. 2011 May-Jun;21(3):415-6 http://hdl.handle.net/10400.17/2310 10.1684/ejd.2011.1288 |
| Idioma(s) |
eng |
| Publicador |
John Libbey Eurotext |
| Direitos |
openAccess |
| Palavras-Chave | #HCC DER #HCC PAT CLIN #Antibodies, Monoclonal, Murine-Derived/therapeutic use #Antigens, CD20 #Autoantibodies/immunology #Desmoglein 1/immunology #Desmoglein 3/immunology #Follow-Up Studies #Immunologic Factors/therapeutic use #Pemphigus/drug therapy #Pemphigus/immunology |
| Tipo |
other |
